T965-0217 Screening compound: 4-[3-(cyclopropylmethoxy)-2-oxo-1-azaspiro[3.5]nonan-1-yl]-N-(3,4-dimethylphenyl)piperidine-1-carboxamide

T965-0217 Screening compound: 4-[3-(cyclopropylmethoxy)-2-oxo-1-azaspiro[3.5]nonan-1-yl]-N-(3,4-dimethylphenyl)piperidine-1-carboxamide
T965-0217 Screening compound: 4-[3-(cyclopropylmethoxy)-2-oxo-1-azaspiro[3.5]nonan-1-yl]-N-(3,4-dimethylphenyl)piperidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T965-0217
4-[3-(cyclopropylmethoxy)-2-oxo-1-azaspiro[3.5]nonan-1-yl]-N-(3,4-dimethylphenyl)piperidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T965-0217

Molecular Formula

C26H37N3O3 (C26 H37 N3 O3)

Compound Name

4-[3-(cyclopropylmethoxy)-2-oxo-1-azaspiro[3.5]nonan-1-yl]-N-(3,4-dimethylphenyl)piperidine-1-carboxamide

IUPAC name

4-[3-(cyclopropylmethoxy)-2-oxo-1-azaspiro[3.5]nonan-1-yl]-N-(34-dimethylphenyl)piperidine-1-carboxamide

SMILES

Cc(cc1)c(C)cc1NC(N(CC1)CCC1N(C1(CCCCC1)C1OCC2CC2)C1=O)=O

InChI

InChI=1S/C26H37N3O3/c1-18-6-9-21(16-19(18)2)27-25(31)28-14-10-22(11-15-28)29-24(30)23(32-17-20-7-8-20)26(29)12-4-3-5-13-26/h6,9,16,20,22-23H,3-5,7-8,10-15,17H2,1-2H3,(H,27,31)/t23-/m0/s1

InChI Key

HXXLUOWFAWCCPY-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD31992546

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

439.6

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.675

Distribution Coefficient, logD

4.675

Water Solubility, LogSw

-4.34

Polar Surface Area

47.882

Acid Dissociation Constant (pKa)

14.09

Base Dissociation Constant (pKb)

2.98

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

69.23

T965-0217 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with T965-0217 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T965-0217?
Check Price and Availability of T965-0217, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T965-0217 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T965-0217
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T965-0217
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T965-0217 available by request